SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-08-057484
Filing Date
2008-03-14
Accepted
2008-03-14 16:48:54
Documents
8
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1247739
2 CLINICAL SERVICES AGREEMENT dex1060.htm EX-10.60 95041
3 CONSENT OF PRICEWATERHOUSECOOPERS dex231.htm EX-23.1 1829
4 CERTIFICATION OF THE CEO PURSUANT TO THE SEC ACT OF 1934 dex311.htm EX-31.1 7428
5 CERTIFICATION OF THE CFO PURSUANT TO THE SEC ACT OF 1934 dex312.htm EX-31.2 7441
6 CERTIFICATION OF THE CEO PURSUANT TO SECTION 906, SARBANES-OXLEY ACT OF 2002 dex321.htm EX-32.1 3526
7 CERTIFICATION OF THE CFO PURSUANT TO SECTION 906, SARBANES-OXLEY ACT OF 2002 dex322.htm EX-32.2 3513
8 GRAPHIC g51512graph.jpg GRAPHIC 53910
  Complete submission text file 0001193125-08-057484.txt   1442353
Mailing Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466
Business Address 4222 EMPEROR BLVD STE 200 DURHAM NC 27703-8466 9199419777
INSPIRE PHARMACEUTICALS INC (Filer) CIK: 0001040416 (see all company filings)

IRS No.: 043209022 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31577 | Film No.: 08690034
SIC: 2834 Pharmaceutical Preparations